Alvarius is a new startup that aims to develop 5-MeO-DMT (originally found in Incilius Alvarius – Colorado River toad) for psychedelic therapy.
The company is funded, in part by Re:Mind Capital (Christian Angermayer).
- James Linder – Co-Founder
- David Nutt – Director
- Psychedelics start-up Alvarius goes on fundraising trip (The Times, January 2021)